純利益率
2005年以降
難易度が低い
計算
Abbott Laboratories、純利益率、長期トレンド、計算
純利益率 | = | 100 | × | 純利益1 | ÷ | 純売上高1 | |
---|---|---|---|---|---|---|---|
2019/12/31 | 11.56% | = | 100 | × | 3,687 | ÷ | 31,904 |
2018/12/31 | 7.74% | = | 100 | × | 2,368 | ÷ | 30,578 |
2017/12/31 | 1.74% | = | 100 | × | 477 | ÷ | 27,390 |
2016/12/31 | 6.71% | = | 100 | × | 1,400 | ÷ | 20,853 |
2015/12/31 | 21.68% | = | 100 | × | 4,423 | ÷ | 20,405 |
2014/12/31 | 11.28% | = | 100 | × | 2,284 | ÷ | 20,247 |
2013/12/31 | 11.79% | = | 100 | × | 2,576 | ÷ | 21,848 |
2012/12/31 | 14.95% | = | 100 | × | 5,963 | ÷ | 39,874 |
2011/12/31 | 12.17% | = | 100 | × | 4,728 | ÷ | 38,851 |
2010/12/31 | 13.15% | = | 100 | × | 4,626 | ÷ | 35,167 |
2009/12/31 | 18.68% | = | 100 | × | 5,746 | ÷ | 30,765 |
2008/12/31 | 16.53% | = | 100 | × | 4,881 | ÷ | 29,528 |
2007/12/31 | 13.92% | = | 100 | × | 3,606 | ÷ | 25,914 |
2006/12/31 | 7.64% | = | 100 | × | 1,717 | ÷ | 22,476 |
2005/12/31 | 15.10% | = | 100 | × | 3,372 | ÷ | 22,338 |
ソース: Abbott Laboratories (NYSE:ABT) | Net profit margin since 2005 (www.stock-analysis-on.net)
1 百万ドル
競合他社との比較
Abbott Laboratories、純利益率、長期トレンド、競合他社との比較
Abbott Laboratories | AbbVie Inc. | Amgen Inc. | Bristol-Myers Squibb Co. | Eli Lilly & Co. | Gilead Sciences Inc. | Illumina Inc. | Johnson & Johnson | Merck & Co. Inc. | Pfizer Inc. | Regeneron Pharmaceuticals Inc. | Vertex Pharmaceuticals Inc. | Zoetis Inc. | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2019/12/31 | 11.56% | 23.69% | 35.32% | 13.15% | 37.27% | 24.35% | 28.28% | 18.42% | 21.01% | 31.45% | 26.91% | 28.27% | 23.96% |
2018/12/31 | 7.74% | 17.36% | 37.25% | 21.81% | 13.16% | 25.16% | 24.78% | 18.75% | 14.71% | 20.79% | 36.42% | 68.80% | 24.52% |
2017/12/31 | 1.74% | 18.82% | 9.08% | 4.85% | -0.89% | 18.03% | 26.38% | 1.70% | 5.97% | 40.55% | 20.41% | 10.59% | 16.28% |
2016/12/31 | 6.71% | 23.22% | 35.27% | 22.94% | 12.90% | 45.07% | 19.29% | 23.01% | 9.85% | 13.66% | 18.42% | -6.58% | 16.80% |
2015/12/31 | 21.68% | 22.50% | 33.13% | 9.45% | 12.07% | 56.32% | 20.79% | 21.99% | 11.25% | 14.25% | 15.50% | -53.89% | 7.11% |
2014/12/31 | 11.28% | 8.89% | 26.69% | 12.62% | 12.19% | 49.44% | 18.98% | 21.96% | 28.22% | 18.42% | 12.34% | -127.25% | 12.18% |
2013/12/31 | 11.79% | 21.97% | 27.93% | 15.64% | 20.27% | 28.46% | 8.82% | 19.40% | 10.00% | 42.65% | 20.16% | -36.72% | 11.05% |
2012/12/31 | 14.95% | 28.70% | 26.11% | 11.12% | 18.09% | 27.57% | 13.17% | 16.14% | 13.05% | 24.70% | 54.43% | -7.01% | 10.06% |
2011/12/31 | 12.17% | — | 24.08% | 17.46% | 17.90% | 34.60% | 8.21% | 14.87% | 13.05% | 14.84% | -49.74% | 2.10% | — |
2010/12/31 | 13.15% | — | 31.56% | 15.92% | 21.97% | 39.26% | 13.83% | 21.65% | 1.87% | 12.18% | -22.76% | -526.35% | — |
2009/12/31 | 18.68% | — | 32.09% | 56.42% | 19.82% | 40.74% | 10.85% | 19.82% | 47.04% | 17.27% | -17.88% | -630.27% | — |
2008/12/31 | 16.53% | — | 28.57% | 25.47% | -10.17% | 39.55% | 8.81% | 20.31% | 32.74% | 16.78% | -34.69% | -262.02% | — |
2007/12/31 | 13.92% | — | 22.12% | 11.19% | 15.85% | 43.27% | -75.89% | 17.31% | 13.54% | 16.82% | -84.46% | -196.61% | — |
2006/12/31 | 7.64% | — | 21.29% | 8.85% | 16.97% | -45.98% | 21.65% | 20.73% | 19.59% | 39.98% | -161.30% | -95.63% | — |
2005/12/31 | 15.10% | — | 30.56% | 15.62% | 13.52% | 44.99% | -28.40% | 20.61% | 21.04% | 15.76% | -144.19% | -126.43% | — |
ソース: Abbott Laboratories (NYSE:ABT) | Net profit margin since 2005 (www.stock-analysis-on.net)
産業部門との比較: 医薬品とバイオテクノロジー
Abbott Laboratories、純利益率、長期トレンド、産業部門との比較: 医薬品とバイオテクノロジー
Abbott Laboratories | 医薬品とバイオテクノロジー | |
---|---|---|
2019/12/31 | 11.56% | 23.19% |
2018/12/31 | 7.74% | 19.80% |
2017/12/31 | 1.74% | 12.42% |
2016/12/31 | 6.71% | 20.64% |
2015/12/31 | 21.68% | 21.84% |
2014/12/31 | 11.28% | 21.52% |
2013/12/31 | 11.79% | 22.06% |
2012/12/31 | 14.95% | 18.62% |
2011/12/31 | 12.17% | 15.49% |
2010/12/31 | 13.15% | 15.20% |
2009/12/31 | 18.68% | 26.25% |
2008/12/31 | 16.53% | 18.77% |
2007/12/31 | 13.92% | 16.05% |
2006/12/31 | 7.64% | 21.43% |
2005/12/31 | 15.10% | 18.36% |
ソース: Abbott Laboratories (NYSE:ABT) | Net profit margin since 2005 (www.stock-analysis-on.net)
業界との比較: 健康管理
Abbott Laboratories、純利益率、長期トレンド、業界との比較: 健康管理
Abbott Laboratories | 健康管理 | |
---|---|---|
2019/12/31 | 11.56% | 16.41% |
2018/12/31 | 7.74% | 14.00% |
2017/12/31 | 1.74% | 9.98% |
2016/12/31 | 6.71% | 14.08% |
2015/12/31 | 21.68% | 15.10% |
2014/12/31 | 11.28% | 15.64% |
2013/12/31 | 11.79% | 16.36% |
2012/12/31 | 14.95% | 14.08% |
2011/12/31 | 12.17% | 13.09% |
2010/12/31 | 13.15% | 12.57% |
2009/12/31 | 18.68% | 18.67% |
2008/12/31 | 16.53% | 13.77% |
2007/12/31 | 13.92% | 13.29% |
2006/12/31 | 7.64% | 15.47% |
2005/12/31 | 15.10% | 15.88% |
ソース: Abbott Laboratories (NYSE:ABT) | Net profit margin since 2005 (www.stock-analysis-on.net)